
    
      Adult subjects with suspected H pylori infection will be recruited and will undergo a 13C
      -Urea breath test (including citrica) with the BreathID test device. Those were found
      positive will undergo selected PPI treatment for 14 days and after 24 or 72 hours from the
      completion of the two weeks, will undergo a second breath test. Those found to be negative
      (false negative), will undergo additional breath tests.

        -  Those subjects that underwent any antibiotic, bismuth or PPI therapy 4 weeks prior to
           the trial, are to be excluded.

        -  Furthermore, pregnant or nursing women and subjects with an allergy or sensitivity to
           one of the tests substrates, will be excluded from the study.
    
  